ReviewFrontiers in pharmacology2026
The pathological mechanisms and potential therapeutic strategies for renal anemia.
Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Renal anemia (RA) is a common complication associated with chronic kidney diseases. Its pathological mechanism is attributed to the combined effects of insufficient production of erythropoietin by the kidneys, iron metabolism disorders, and chronic inflammatory conditions. The main pillars of medicine treatment for these aspects include erythropoiesis-stimulating agents, iron supplementation, and novel hypoxia-inducible factor prolyl hydroxylase inhibitors. Traditional Chinese medicine shows potential advantages across multiple targets in improving anemia and renal function in patients with RA. This review aims to systematically explain the current pathophysiological understanding of RA, examine the prevailing treatment approaches, and summarize the pharmacological mechanisms and research findings related to natural products and their active compounds used in RA treatment. This review is to provide new insights and references to support future in-depth research and clinical management of RA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.